Abstract | BACKGROUND/AIMS:
Actinic keratosis area and severity index (AKASI) is a new assessment tool to quantify the severity of actinic damage on the head. Thus far, it has not been evaluated in monitoring the efficacy of field-directed topical treatments in actinic keratosis (AK) in routine clinical practice. Thus, the aim of this study was to determine treatment outcomes by using AKASI 3 months after the initiation of topical application of diclofenac sodium 3% in hyaluronic acid 2.5% gel (DFS) in patients with AKs on the head. METHODS: We performed a retrospective analysis of patients with AKs who had AKASI scores prior to and after treatment with DFS. RESULTS: Of the 24 patients included, 20 (83.3%) showed an improvement in AKASI, 2 (8.3%) a stable AKASI, and 2 (8.3%) a worsening of AKASI after a median (interquartile range) follow-up period of 91.5 days (89.8-104.3). The median AKASI reduction was 31.4% (16.7-59.1). The Wilcoxon test showed significant differences (p = 0.0008) between baseline and posttreatment AKASI values. CONCLUSIONS: AKASI is an easy-to-use quantitative tool for assessing the treatment outcome of field-directed therapies. Field-directed therapies of AK should no longer be monitored by assessments based on lesion counts alone.
|
Authors | Lutz Schmitz, Girish Gupta, Marc Hanno Segert, Ricarda Kost, Julia Sternberg, Thilo Gambichler, Eggert Stockfleth, Thomas Dirschka |
Journal | Skin pharmacology and physiology
(Skin Pharmacol Physiol)
Vol. 31
Issue 4
Pg. 206-211
( 2018)
ISSN: 1660-5535 [Electronic] Switzerland |
PMID | 29791916
(Publication Type: Journal Article)
|
Copyright | © 2018 S. Karger AG, Basel. |
Chemical References |
- Dermatologic Agents
- Gels
- Diclofenac
- Hyaluronic Acid
|
Topics |
- Administration, Cutaneous
- Aged
- Aged, 80 and over
- Dermatologic Agents
(administration & dosage, therapeutic use)
- Diclofenac
(administration & dosage, therapeutic use)
- Female
- Follow-Up Studies
- Gels
- Humans
- Hyaluronic Acid
(administration & dosage, therapeutic use)
- Keratosis, Actinic
(drug therapy, pathology)
- Male
- Retrospective Studies
- Severity of Illness Index
- Statistics, Nonparametric
- Treatment Outcome
|